BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34245799)

  • 1. The next generation: Urinary epidermal growth factor is associated with an early decline in kidney function in children and adolescents with type 1 diabetes mellitus.
    Ledeganck KJ; den Brinker M; Peeters E; Verschueren A; De Winter BY; France A; Dotremont H; Trouet D
    Diabetes Res Clin Pract; 2021 Aug; 178():108945. PubMed ID: 34245799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
    BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.
    Li B; Zhang Y; Wang F; Nair V; Ding F; Xiao H; Yao Y; Kretzler M; Ju W; Ding J
    Pediatr Nephrol; 2018 Oct; 33(10):1731-1739. PubMed ID: 29948307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Betz BB; Jenks SJ; Cronshaw AD; Lamont DJ; Cairns C; Manning JR; Goddard J; Webb DJ; Mullins JJ; Hughes J; McLachlan S; Strachan MWJ; Price JF; Conway BR
    Kidney Int; 2016 May; 89(5):1125-1135. PubMed ID: 27083286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
    Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
    Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Epidermal Growth Factor: A Promising "Next Generation" Biomarker in Kidney Disease.
    Cortvrindt C; Speeckaert R; Delanghe JR; Speeckaert MM
    Am J Nephrol; 2022; 53(5):372-387. PubMed ID: 35537382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
    Chiarelli F; Verrotti A; Mohn A; Morgese G
    Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?
    Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O
    Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus.
    Metwalley KA; Farghaly HS; Gabri MF; Abdel-Aziz SM; Ismail AM; Raafat DM; Elnakeeb IF
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):293-299. PubMed ID: 33565751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Azukaitis K; Ju W; Kirchner M; Nair V; Smith M; Fang Z; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Yalcinkaya F; Paripovic D; Harambat J; Cakar N; Alpay H; Lugani F; Mencarelli F; Civilibal M; Erdogan H; Gellermann J; Vidal E; Tabel Y; Gimpel C; Ertan P; Yavascan O; Melk A; Querfeld U; Wühl E; Kretzler M; Schaefer F; ;
    Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy.
    Mathiesen ER; Nexø E; Hommel E; Parving HH
    Diabet Med; 1989 Mar; 6(2):121-6. PubMed ID: 2522852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis.
    Wu L; Li XQ; Goyal T; Eddy S; Kretzler M; Ju WJ; Chen M; Zhao MH
    Ann Rheum Dis; 2018 Sep; 77(9):1339-1344. PubMed ID: 29724728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma leucine-rich α-2-glycoprotein 1 - a novel marker of diabetic kidney disease in children and adolescents with type 1 diabetes mellitus?
    Altıncık SA; Yıldırımçakar D; Avcı E; Özhan B; Girişgen İ; Yüksel S
    Pediatr Nephrol; 2023 Dec; 38(12):4043-4049. PubMed ID: 37401956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy.
    Zhou J; Sun S; Zhang D; Mao J; Xiao H; Yao Y; Wang F; Yu L; Liu L; Feng C; Li C; Su B; Zhang H; Liu X; Xu K; Ju W; Zhong X; Ding J
    Pediatr Res; 2023 Aug; 94(2):747-755. PubMed ID: 36864281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Study of the Risk Factors and Urinary Podocin as an Early Prognostic Indicator of Renal Injury in Diabetic Nephropathy.
    Kondapi K; Silambanan S; Moorthy S; Kumar NL
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.